Omega Point · Lab
Hypotheses
Every hypothesis every run has written, newest run first. Each row says where it is: being named, waiting for the rest of its run, checked for duplicates, approved and being explained, published. A duplicate names the earlier hypothesis it restates. A published row links to its public page; nothing else is a link.
Run: pipeline-a07472572491the run
| Hypothesis▲ | Question asked▲ | Date▼ | Engine▲ | Lens▲ | Status▲ |
|---|---|---|---|---|---|
| Replacing fat reserves and complete movement units is enough to prevent lasting decline IH_Q_L3_M_G1_1_05 · #4 Replacing 20% of age-60 gluteofemoral fat and complete motor units, with associated tendon replacement, would preserve recovery after illness or inactivity. The combined set must meet the full clinical outcome pattern; isolated strength or insulin-sensitivity gains reject it. Explains the gap: Which anatomical structures and cellular compartments constitute a sufficient replacement set when randomized omissions, rival combinations, and equivalent-care controls must distinguish necessity from compensation across all five functional domains and survival over 20 years? Void gap | What is the minimum amount of tissue—and exactly which parts—that needs to be replaced to slow down aging and extend lifespan? | 2026-09-16 20:46 | 1.1 | candidate set selection | Published live 2026-09-18 Published · poster live |
| Can replacing biased blood-forming stem cells alone deliver lasting benefits against aging? IH_Q_L3_M_G1_2_05 · #9 Replacing 90% of myeloid-biased long-term hematopoietic stem cells—blood-forming cells biased toward myeloid output—with balanced-output cells is proposed to suffice through year 20. Stable balanced donor–host output without multidomain and survival benefit would falsify the claim. Explains the gap: How many cumulative grams per person and what percentages of each named functional unit remain necessary after experimental fraction and schedule reduction, counting growth and repeats over 20 years, and where do these minima conflict? Void gap | What is the minimum amount of tissue—and exactly which parts—that needs to be replaced to slow down aging and extend lifespan? | 2026-09-16 20:46 | 1.1 | candidate set selection | Published live 2026-09-18 Published · poster live |
| Apparent benefits of timing alignment after partial tissue replacement are measurement artifacts IH_Q_L3_M_G1_3_05 · #14 Timing alignment does not reproducibly rescue reduced-fraction tissue replacement under equivalent exposure. Comparisons that control testing and selection biases would show no clinically meaningful fluid-recovery or cognition benefit, and independently fitted stability models would fail held-out prediction. Explains the gap: Can physiological phase realignment rescue a failing reduced-fraction replacement without adding tissue, and does the Nyquist stability criterion predict when ordinary meal, posture, and activity shifts reverse that rescue? Fragile gap | What is the minimum amount of tissue—and exactly which parts—that needs to be replaced to slow down aging and extend lifespan? | 2026-09-16 20:46 | 1.1 | Measurement and interpretation | Published live 2026-09-18 Published · poster live |
| Blocked muscle capillaries prolong recovery during overlapping treatment and infection IH_Q_L3_M_G1_4_05 · #19 Persistent platelet-fibrin blockages could delay insulin delivery and immune-cell access in skeletal muscle. Reopening capillaries should restore delivery and muscle performance; restoring insulin signaling without reopening them should fail. Explains the gap: Does stronger graft protection or faster normalization of insulin sensitivity prolong infection recovery, and can a staged immune-metabolic regimen preserve graft function while preventing subsequent physical decline? Clash gap | What is the minimum amount of tissue—and exactly which parts—that needs to be replaced to slow down aging and extend lifespan? | 2026-09-16 20:46 | 1.1 | Structure and topology | Published live 2026-09-18 Published · poster live |
| Replacement preparation can leave lasting mutations that cancel the graft’s benefits IH_Q_L3_M_G1_5_05 · #24 For replacement strategies requiring preparation that damages DNA, lasting mutations in retained blood-forming and epithelial stem cells could offset restored reserve. Matched graft success with fewer new mutations, less delayed disease and better functional survival after non-damaging preparation would support this claim. Explains the gap: If replacement durably restores the predicted limiting reserve, yet fails to slow decline in all five domains or extend independent survival, does that falsify the bottleneck-replacement framework despite successful engraftment? Adversarial gap | What is the minimum amount of tissue—and exactly which parts—that needs to be replaced to slow down aging and extend lifespan? | 2026-09-16 20:46 | 1.1 | somatic genotoxic legacy | Published live 2026-09-18 Published · poster failed |
| The apparent cognitive deficit during walking and posture changes comes from measurement errors IH_Q_L3_M_G2_1_05 · #29 During walking and posture changes, testing conditions create apparent cognitive impairment. With the same walking dose, verified stimulus delivery and delayed stationary recognition should remove the timing effect; persistent delayed deficits across testing modes would falsify this account. Explains the gap: Can combined walking and posture transitions reproducibly impair cognition despite adequate isolated organ reserves, and can changing transition timing prevent impairment without reducing total activity? Adversarial gap | What is the minimum amount of tissue—and exactly which parts—that needs to be replaced to slow down aging and extend lifespan? | 2026-09-16 20:46 | 1.1 | Measurement and interpretation | Published live 2026-09-18 Published · poster live |
| Restored muscle overwhelms the liver's energy capacity to recycle lactate into glucose IH_Q_L3_M_G2_2_05 · #34 Restored muscle may overwhelm the retained liver's energy supply for recycling lactate into glucose during activity and recovery. The claim fails if liver energy status stays preserved and glucose production remains below its limit throughout symptomatic episodes. Explains the gap: Does restored muscle glucose uptake destabilize meal–activity control by increasing feedback gain, and can phase realignment restore damping without changing tissue quantity, calories, or activity? Fragile gap | What is the minimum amount of tissue—and exactly which parts—that needs to be replaced to slow down aging and extend lifespan? | 2026-09-16 20:46 | 1.1 | Resource and energy | Published live 2026-09-18 Published · poster live |
| Delayed gut delivery of rehydration fluid leaves the kidneys and brain undersupplied IH_Q_L3_M_G2_3_05 · #39 During supervised oral rehydration, retained fluid may remain in the gut rather than restore circulation. The hypothesis predicts that kidney filtration and brain recovery track water entering circulation; matching that entry across drinking schedules should eliminate their renal difference. Explains the gap: Does successful fluid conservation during heat create the subsequent renal deficit through venous congestion, and can staged rehydration prevent that reversal while preserving cerebral perfusion? Clash gap | What is the minimum amount of tissue—and exactly which parts—that needs to be replaced to slow down aging and extend lifespan? | 2026-09-16 20:46 | 1.1 | Interfaces and barriers | Published live 2026-09-18 Published · poster live |
| Active drug exposure drives the apparent trade-off between activity and infection control IH_Q_L3_M_G2_4_05 · #44 In recipients receiving tacrolimus, a drug that suppresses immune activity, active drug exposure would explain delayed infection clearance and impaired function. Outcomes tracking unbound drug, and improvement after exposure correction without changing activity policy, would distinguish this explanation. Explains the gap: During infection, does preserving restored locomotor output prolong illness by defeating protective demand shedding, or does downshifting instead cause persistent neural-contractile loss that erases its benefit? | What is the minimum amount of tissue—and exactly which parts—that needs to be replaced to slow down aging and extend lifespan? | 2026-09-16 20:46 | 1.1 | System and environment | Published live 2026-09-18 Published · poster live |
| Mitochondrial genome deletions hide a loss of muscle energy reserve IH_Q_L3_M_G2_5_05 · #49 Retained muscle fibers may conceal lost energy reserve by recruiting unaffected segments and motor units. The hypothesis predicts that intolerance maps to mitochondrial genome deletions despite abundant oxygen and fuel; normal intrinsic respiration in affected regions argues against it. Explains the gap: Does apparent recovery conceal persistent microvascular reserve loss that makes repeat output gains dangerous, or do recurrent deficits reflect reversible timing mismatch rather than cumulative structural injury? | What is the minimum amount of tissue—and exactly which parts—that needs to be replaced to slow down aging and extend lifespan? | 2026-09-16 20:46 | 1.1 | Resource and energy | Published live 2026-09-18 Published · poster failed |
| Persistent protein seeds make replacement tissue fail sooner IH_Q_L3_M_G3_1_05 · #54 In models expressing human islet amyloid polypeptide (IAPP), persistent protein seeds would make later endocrine grafts fail sooner at previously affected sites. Removing seeds should reset time to failure; transferring cell-free seed-containing material should shorten it at an unused site. Explains the gap: Can smaller, dispersed replacements require more cumulative tissue because interface exposure and compensatory workload shorten useful life faster than smaller procedures shorten recovery? Fragile gap | What is the minimum amount of tissue—and exactly which parts—that needs to be replaced to slow down aging and extend lifespan? | 2026-09-16 20:46 | 1.1 | proteostatic templating | Published live 2026-09-17 Published · poster live |
| Senescent-cell secretions change lymphatic pumping and determine when suppression helps IH_Q_L3_M_G3_2_05 · #59 Secretions from senescent cells may shift lymphatic muscle from effective pulses to sustained activation. Changes within minutes to hours and rescue by adjusting neurokinin signaling would distinguish this pumping mechanism from loss of tissue repair. Explains the gap: Does suppressing interface senescence after infection prevent reimpairment, or remove the repair program needed to restore drainage and perfusion—and what intervention timing separates these outcomes? Clash gap | What is the minimum amount of tissue—and exactly which parts—that needs to be replaced to slow down aging and extend lifespan? | 2026-09-16 20:46 | 1.1 | Information and sensing | Published live 2026-09-17 Published · poster live |
| Meal shifts leave liver enzymes assembled in a persistent low-activity state IH_Q_L3_M_G3_3_05 · #64 In human liver constructs, persistent enzyme assemblies could explain delayed metabolic output after meal shifts. A selective change that prevents assembly while preserving baseline enzyme activity would eliminate the lag; increased exchange between compartments would not. Explains the gap: Does host–replacement metabolic coordination obey an Adler phase-locking threshold, such that modest meal shifts cause persistent desynchronization despite adequate local clocks, and can increasing coupling restore function without additional tissue? Fragile gap | What is the minimum amount of tissue—and exactly which parts—that needs to be replaced to slow down aging and extend lifespan? | 2026-09-16 20:46 | 1.1 | protein assembly hysteresis | Published live 2026-09-18 Published · poster live |
| Surviving replacement muscle stays weak because too few myosin motors become active IH_Q_L3_M_G3_4_05 · #69 In surviving replacement muscle fibers, inhibited myosin motors limit force despite adequate activation and adenosine triphosphate (ATP). Abnormal motor kinetics under controlled conditions, and restored force after verified motor-state correction, would distinguish this mechanism from its rivals. Explains the gap: When replacement tissue remains viable after illness, can restoring neural recruitment and physiological loading recover lost output without renewal, disproving the assumption that declining function means insufficient surviving tissue? | What is the minimum amount of tissue—and exactly which parts—that needs to be replaced to slow down aging and extend lifespan? | 2026-09-16 20:46 | 1.1 | contractile enzyme state | Published live 2026-09-17 Published · poster live |
| Conditioning releases host protein seeds that shorten replacement tissue durability IH_Q_L3_M_G3_5_05 · #74 In amyloid-characterized aged rodent hepatic replacement models, conditioning may improve initial engraftment but spread harmful protein shapes. Transfer of the effect by interface eluate, and its loss after seed depletion despite identical handoff delays, would distinguish this mechanism. Explains the gap: Can staged boundary conditioning worsen durable function despite better engraftment because delayed handoff exhausts native reserve, and would matched replacement without conditioning preserve more function through repeated ordinary stress? | What is the minimum amount of tissue—and exactly which parts—that needs to be replaced to slow down aging and extend lifespan? | 2026-09-16 20:46 | 1.1 | templated protein propagation | Published live 2026-09-18 Published · poster live |
| Poor delivery of immune defenses across graft barriers lets infection persist IH_Q_L3_M_G4_1_05 · #79 In epithelial replacements, infection can persist because neutralizing defenses do not reach the lumen despite effective surveillance on the tissue side. Direct luminal delivery should accelerate clearance without changing abnormal-clone killing; persistence despite adequate delivery would refute the explanation. Explains the gap: Does durable graft acceptance create a compartment where infection or abnormal clones escape surveillance, and can antigen-specific tolerance separate these outcomes better than immune cloaking at matched functional engraftment? | What is the minimum amount of tissue—and exactly which parts—that needs to be replaced to slow down aging and extend lifespan? | 2026-09-16 20:46 | 1.1 | Interfaces and barriers | Published live 2026-09-18 Published · poster live |
| Early movement can increase drug absorption through skin and harm brain or kidney recovery IH_Q_L3_M_G4_2_05 · #84 In susceptible recipients already prescribed drugs delivered through skin, early mobilization may trigger drug peaks that impair brain or kidney recovery. Eliminating those peaks while preserving the drug's intended effect would retain the mechanical benefit without excess remote harm. Explains the gap: Can earlier protected mobilization improve graft mechanics yet worsen cerebral or renal recovery compared with reserve-gated mobilization, even when both schedules satisfy local healing limits? | What is the minimum amount of tissue—and exactly which parts—that needs to be replaced to slow down aging and extend lifespan? | 2026-09-16 20:46 | 1.1 | xenobiotic release kinetics | Published live 2026-09-17 Published · poster live |
| Scar binding chemistry restricts molecular exchange IH_Q_L3_M_G4_3_05 · #89 In microfluidic interfaces, scar binding sites would retain charged solutes and native proteins while sparing neutral tracers and bulk water. Restoring exchange by modifying those sites, with collagen connectivity and wound strength unchanged, would distinguish chemical trapping from a structural barrier. Explains the gap: At equal scar mass, does crossing a collagen-network percolation threshold cause interface restriction, and can selectively breaking network connectivity restore exchange without reopening the wound? Proxy gap | What is the minimum amount of tissue—and exactly which parts—that needs to be replaced to slow down aging and extend lifespan? | 2026-09-16 20:46 | 1.1 | physicochemical partitioning | Published live 2026-09-18 Published · poster live |
| Unequal test timing creates the apparent harm from meal timing after tissue replacement IH_Q_L3_M_G4_4_05 · #94 In tissue-replacement studies, apparent meal-timing harm reflects when testing occurs relative to biological rhythms and feeding. The claim predicts no worsening of performance across the day or sustained recovery; a persistent functional deficit with a mechanism-specific rescue would refute it. Explains the gap: Does aligning meals with sleep worsen recovery when replacement tissue and host liver remain out of phase, despite improving average glucose, and does tissue-phase alignment reverse that harm? Fragile gap | What is the minimum amount of tissue—and exactly which parts—that needs to be replaced to slow down aging and extend lifespan? | 2026-09-16 20:46 | 1.1 | Measurement and interpretation | Published live 2026-09-17 Published · poster live |
| Genuine recovery leaves no extra treatment-history damage within the tested procedure class IH_Q_L3_M_G4_5_05 · #99 Randomized animal schedules followed from the first attempt test whether treatment history adds clinically meaningful harm after genuine recovery. Accounting for age, actual procedural injury, repeated recovery measurements, death and non-recovery should remove the apparent extra harm. Explains the gap: Does apparent recovery between replacements erase treatment debt, or do clinically recovered recipients retain sequence-dependent damage that makes the next identical procedure disproportionately disabling? Fragile gap | What is the minimum amount of tissue—and exactly which parts—that needs to be replaced to slow down aging and extend lifespan? | 2026-09-16 20:46 | 1.1 | Measurement and interpretation | Published live 2026-09-17 Published · poster live |